-
Product Insights
NewLikelihood of Approval Analysis for Paramyxoviridae Infections
Overview How likely is it that the drugs in Paramyxoviridae Infections will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Paramyxoviridae Infections Overview The Paramyxoviridae family belongs to the order Mononegavirales, the...
-
Product Insights
NewLikelihood of Approval Analysis for Togaviridae Infections
Overview How likely is it that the drugs in Togaviridae Infections will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Togaviridae Infections Overview The Togaviridae is a family of enveloped, single-stranded, plus-strand...
-
Product Insights
NewLikelihood of Approval Analysis for Human Immunodeficiency Virus (HIV) Infections (AIDS)
Overview How likely is it that the drugs in Human Immunodeficiency Virus (HIV) Infections (AIDS) will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Human Immunodeficiency Virus (HIV) Infections (AIDS) Overview Human...
-
Product Insights
NewLikelihood of Approval Analysis for Human Papillomavirus Infections
Overview How likely is it that the drugs in Human Papillomavirus Infections will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Human Papillomavirus Infections Overview Human Papillomavirus (HPV) infections are common sexually...
-
Product Insights
NewLikelihood of Approval Analysis for Filoviridae Infections
Overview How likely is it that the drugs in Filoviridae Infections will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Filoviridae Infections Overview Filovirideae infections are caused by viruses in the family...
-
Product Insights
NewLikelihood of Approval Analysis for Hepatitis B
Overview How likely is it that the drugs in Hepatitis B will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Hepatitis B Overview Hepatitis B, a viral infection affecting the liver, poses...
-
Product Insights
NewLikelihood of Approval Analysis for Demyelinating Diseases
Overview How likely is it that the drugs in Demyelinating Diseases will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Demyelinating Diseases Overview Demyelinating diseases encompass conditions where the protective myelin sheath...
-
Sector Analysis
NewEdge Computing Market Size, Trends and Analysis by IT Infrastructure, Vertical, Employee Size Band, Region and Segment Forecast to 2027
Accessing the in-depth insights from the ‘Edge Computing’ report can help: Understand the current and future state of the market, allowing businesses to make informed decisions about market entry, product development, and Identify competitors' capabilities to stay ahead in the market. Identify segments and know the stakeholders across different stages of the value Anticipate changes in demand and adjust the business development strategies Identify potential regions and countries for growth How is our ‘Edge Computing’ report different from other reports...
-
Analyst Opinions
Net Zero by 2050 – Industrial Decarbonization Gains Momentum (Vol.2)
Net Zero by 2050 Overview Businesses and tech giants globally are focusing on low-carbon products, renewables, and EVs to achieve net zero emissions. Key sectors such as aerospace, automotive, and technology are advancing sustainability through innovations in hydrogen, EVs, fuel cells, and smart energy solutions among others. The “Net Zero by 2050” report outlines decarbonization-related deals value and volume trends, VC investment activity and geographic trends, and leading investors. The report also provides facts and figures related to climate change,...
-
Sector Analysis
Asia Pacific (APAC) Renewable Energy Policy Handbook, 2024 Update
Asia Pacific (APAC) Renewable Energy Policy Report Overview All Asia Pacific (APAC) countries covered in this report have set targets for renewable energy deployment and generation. A few countries have capacity targets, and a few have generation targets. In the APAC region, feed-in tariff (FiT) has been predominantly the most popular form of incentive utilized to promote renewable power installations. However, competitive bidding or auctions have also gained popularity in the APAC countries to promote renewable energy, especially solar PV,...